Title: Double-conditioning regimen with thiotepa and melphalan
for high-risk neuroblastoma
Authors: Fumito Yamazaki1,2, Kai
Yamasaki3, Chikako Kiyotani1,
Yoshiko Hashii4, Yoko Shioda1,
Junichi Hara3, Kimikazu Matsumoto1.
Authors Affiliations: 1National Center for
Child Health and Development, Children’s Cancer Center, Tokyo, Japan
2Keio University School of Medicine, Department of
Pediatrics, Tokyo, Japan
3Osaka City General Hospital, Department of Pediatric
Hematology and Oncology, Osaka, Japan
4Osaka University Hospital, Department of Pediatrics,
Osaka, Japan
Corresponding authors: Kimikazu Matsumoto, MD, PhD
National Center for Child Health and Development, Children’s Cancer
Center, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Tel: +81-3-3416-0181, Fax: +81-3-3416-2222, E-mail:
matsumoto-kmk@ncchd.go.jp
Word Counts: Abstract 245 words, Main text 2340 words
The Number of Tables and Figures: 2 Tables, 2 Figures, 1
Supporting Information file
Running Title: Thiotepa and melphalan for high-risk
neuroblastoma
Key Words: neuroblastoma, thiotepa, melphalan